ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.37
-0.39 (-3.62%)
Nov 13, 2026, 3:00 PM CST
SHA:600479 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 705.95 | 780.15 | 1,344 | 1,998 | 1,240 | 632.88 |
Short-Term Investments | - | - | - | - | 182 | 51.94 |
Trading Asset Securities | 1.26 | 1.94 | 4.76 | - | 491.74 | 736.84 |
Cash & Short-Term Investments | 707.21 | 782.08 | 1,349 | 1,998 | 1,914 | 1,422 |
Cash Growth | 24.71% | -42.03% | -32.47% | 4.40% | 34.61% | -5.74% |
Accounts Receivable | 924.72 | 819.27 | 823.34 | 912.54 | 847.17 | 830.93 |
Other Receivables | 98.66 | 18.01 | 21.92 | 28.26 | 27.83 | 31.23 |
Receivables | 1,023 | 837.28 | 845.26 | 940.8 | 875 | 862.16 |
Inventory | 518.46 | 490.35 | 485.94 | 534.14 | 598.99 | 547.78 |
Prepaid Expenses | - | - | - | 0.24 | 0.73 | 3.44 |
Other Current Assets | 75.23 | 53.89 | 48.48 | 41.4 | 125.07 | 82.22 |
Total Current Assets | 2,324 | 2,164 | 2,729 | 3,514 | 3,513 | 2,917 |
Property, Plant & Equipment | 618.31 | 606.08 | 561.31 | 589.93 | 547.02 | 630.19 |
Long-Term Investments | 1,771 | 1,812 | 953.32 | 247.61 | 187.59 | 190.77 |
Goodwill | 14.07 | 14.07 | 14.07 | 14.07 | 14.07 | 14.07 |
Other Intangible Assets | 274.72 | 231.77 | 208.22 | 212.21 | 195.11 | 201.9 |
Long-Term Deferred Tax Assets | 25.28 | 22.94 | 16.97 | 22.67 | 19.29 | 4.12 |
Long-Term Deferred Charges | 70.27 | 90.43 | 67.44 | 71.73 | 71.41 | 76.98 |
Other Long-Term Assets | 76.42 | 22.68 | 6.03 | 4.18 | 86.64 | 24.93 |
Total Assets | 5,174 | 4,964 | 4,556 | 4,677 | 4,635 | 4,060 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 762.11 | 702.98 | 565.64 | 647.49 | 780.92 | 511.67 |
Accrued Expenses | 137.31 | 404.26 | 376.14 | 402.93 | 376.04 | 267.41 |
Short-Term Debt | 91.02 | 59.71 | 11.9 | 56.69 | 58.13 | 67.09 |
Current Portion of Long-Term Debt | 14.07 | - | 7 | 5 | 3.5 | 3 |
Current Portion of Leases | - | 13.32 | 13.78 | 16.56 | 17.84 | 18.55 |
Current Income Taxes Payable | 43.74 | 17.13 | 3.63 | 37.28 | 31.29 | 23.89 |
Current Unearned Revenue | 73.42 | 98.24 | 95.27 | 123.61 | 131.21 | 99.59 |
Other Current Liabilities | 502.96 | 195.47 | 259.43 | 252.27 | 298.3 | 237.22 |
Total Current Liabilities | 1,625 | 1,491 | 1,333 | 1,542 | 1,697 | 1,228 |
Long-Term Debt | - | - | - | 7 | 12 | 15.5 |
Long-Term Leases | 23.65 | 28.51 | 25.96 | 31.46 | 32.76 | 44.79 |
Long-Term Unearned Revenue | 55.02 | 62.11 | 33.66 | 38.04 | 44.44 | 51.27 |
Pension & Post-Retirement Benefits | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 |
Long-Term Deferred Tax Liabilities | 27.94 | 23.83 | 17.65 | 24.72 | 24.06 | 13.22 |
Other Long-Term Liabilities | 5.19 | 6.05 | 5.19 | 5.19 | 5.19 | 5.19 |
Total Liabilities | 1,738 | 1,614 | 1,417 | 1,650 | 1,818 | 1,360 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 492.21 | 492.21 | 424 | 428.92 | 429.81 | 418.51 |
Additional Paid-In Capital | 941.63 | 941.57 | 603.25 | 631.18 | 635.44 | 585.49 |
Retained Earnings | 1,663 | 1,593 | 1,450 | 1,363 | 1,192 | 1,146 |
Treasury Stock | - | - | -16.56 | -35.02 | -41.81 | - |
Comprehensive Income & Other | 1.69 | 1.76 | 1.58 | 1.59 | 1.4 | 0.75 |
Total Common Equity | 3,099 | 3,028 | 2,462 | 2,390 | 2,217 | 2,150 |
Minority Interest | 336.89 | 321.86 | 676.87 | 637.08 | 600.07 | 549.55 |
Shareholders' Equity | 3,436 | 3,350 | 3,139 | 3,027 | 2,817 | 2,700 |
Total Liabilities & Equity | 5,174 | 4,964 | 4,556 | 4,677 | 4,635 | 4,060 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 128.74 | 101.54 | 58.64 | 116.71 | 124.24 | 148.93 |
Net Cash (Debt) | 578.46 | 680.55 | 1,291 | 1,881 | 1,789 | 1,273 |
Net Cash Growth | 12.98% | -47.27% | -31.39% | 5.13% | 40.60% | -5.93% |
Net Cash Per Share | 1.19 | 1.58 | 3.12 | 4.45 | 4.18 | 3.04 |
Filing Date Shares Outstanding | 492.21 | 492.21 | 424 | 428.92 | 428.12 | 418.51 |
Total Common Shares Outstanding | 492.21 | 492.21 | 424 | 428.92 | 428.12 | 418.51 |
Working Capital | 699.65 | 672.49 | 1,396 | 1,973 | 1,816 | 1,689 |
Book Value Per Share | 6.30 | 6.15 | 5.81 | 5.57 | 5.18 | 5.14 |
Tangible Book Value | 2,810 | 2,782 | 2,240 | 2,163 | 2,008 | 1,934 |
Tangible Book Value Per Share | 5.71 | 5.65 | 5.28 | 5.04 | 4.69 | 4.62 |
Buildings | - | 819.48 | 799.74 | 780.42 | 765.95 | 650.15 |
Machinery | - | 531.27 | 491.41 | 485.55 | 395.8 | 436.31 |
Construction In Progress | - | 32.45 | 13.35 | 6.12 | 5.78 | 94.34 |